Effects of the European restrictive actions concerning nimesulide prescription: A simulation study on hepatopathies and gastrointestinal bleedings in Italy

Annali dell'Istituto Superiore di Sanita

Volumn 46, Issue 2, 2010, Pages 153-157

  Venegoni, Mauro ^a   Da Cas, Roberto ^a   Menniti Ippolito, Francesca ^a   Traversa, Giuseppe ^b  

^a Centro Regionale di Farmacovigilanza   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Adverse drug reaction; Hepatotoxicity; Nimesulide; Upper gastrointestinal bleeding

Indexed keywords

NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONAMIDE;

ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG LEGISLATION; EUROPE; GASTROINTESTINAL HEMORRHAGE; HUMAN; ITALY; PRESCRIPTION; STANDARD; TOXIC HEPATITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG PRESCRIPTIONS; DRUG-INDUCED LIVER INJURY; EUROPE; GASTROINTESTINAL HEMORRHAGE; HUMANS; ITALY; LEGISLATION, DRUG; SULFONAMIDES;

EID: 77955612747     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: 10.4415/ANN-10-02-08     Document Type: Article

References (11)

1. Traversa G, Bianchi C, Da Cas R, Abraha I, Menniti-Ippolito F, Venegoni M. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. BMJ 2003;327:18-22.
2. Walker SL, Kennedy F, Niamh N, McCormick PA. Nimesulide associated fulminant hepatic failure. Pharmacoepidemiol Drug Saf 2008;17:1108-1112
3. EMEA Press Release 21 September 2007. Available from: http://www.emea.europa.eu/pdfs/human/press/pr/32370307en.pdf.
4. EMA Press Release 25 February 2010. Available from: http://www.ema. europa.eu/pdfs/human/press/pr/10885010en.pdf.
5. Laporte JR, Ibanez L, Vidal X, Vendrell L, Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Safety 2004;27:411-420
6. Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000; 160:2093-2099
7. Garcia-Rodriguez LA, Cattaruzzi G, Troncon MG, Agostinis L. Risk of hospitalisation for upper gastrointestinal tract bleeding associated with ketorolac, other non-steroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998;158:33-39
8. Menniti-Ippolito F, Maggini M, Raschetti R, Da Cas R, Traversa G, Walker AM. Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non-steroidal anti-inflammatory drugs in Italy. Eur J Clin Pharmacol 1998;54:393-397
9. Helin-Salmivaara A, Saarelainen S, Grönroos JM, Vesalainen R, Klaukka T, Huupponen R. Risk of upper gastrointestinal events with the use of various NSAIDs: a case-control study in a general population. Scand J Gastroenterol 2007; 42:923-932 (Pubitemid 47037118)
10. Licata A, Calvaruso V, Cappello M, Craxì A, Almasio PL. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication. Dig Liver Dis 2010;42:143-148
11. Lanas A, Perez-Aisa MA, Feu F, Ponce J, Saperas E, Santolaria S, Rodrigo L, Balanzo J, Bajador E, Almela P, Navarro JM, Carballo F, Castro M, Quintero E; Investigators of the Asociación Española de Gastroenterología (AEG). A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with non-steroidal anti-inflammatory drug use. Am J Gastroenterol 2005;100:1685-1693